Overview

CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops

Status:
Recruiting
Trial end date:
2022-12-15
Target enrollment:
Participant gender:
Summary
CHED- Congenital Endothelial Endothelial Dystrophy is a condition that causes corneal cloudiness. Since, currently only surgery is being done to cure this condition, we are taking up the research of using topical eye drops for this condition which is a very simple and easy method. Also, there are no significant side effects to this treatment.
Phase:
Phase 2
Details
Lead Sponsor:
L.V. Prasad Eye Institute
Collaborator:
Allergan
Treatments:
Carboxymethylcellulose Sodium
Lubricant Eye Drops
Nepafenac
Ophthalmic Solutions